+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

  • ID: 4856478
  • Report
  • November 2019
  • Region: Global
  • 49 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott Diagnostics
  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Pax Neuroscience Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019

Summary
The author's Medical Devices sector report, “Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019 provides an overview of Central Nervous Systems Therapeutic Drug Monitoring currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Nervous Systems Therapeutic Drug Monitoring pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by The author's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Central Nervous Systems Therapeutic Drug Monitoring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Nervous Systems Therapeutic Drug Monitoring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy
The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Nervous Systems Therapeutic Drug Monitoring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Diagnostics
  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Pax Neuroscience Inc

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Central Nervous Systems Therapeutic Drug Monitoring Overview
3 Products under Development
3.1 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
3.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
3.3 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
3.4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
4 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
4.1 Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
4.2 Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
5 Central Nervous Systems Therapeutic Drug Monitoring Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 ARK Diagnostics Inc Company Overview
5.2.1 ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Avacta Group Plc Company Overview
5.3.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.4 ELITechGroup Inc Company Overview
5.4.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Nipro Europe N.V. Company Overview
5.5.1 Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Pax Neuroscience Inc Company Overview
5.6.1 Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Saladax Biomedical Inc Company Overview
5.7.1 Saladax
Biomedical
Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Siemens Healthineers AG Company Overview
5.8.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.9 University of Colorado Company Overview
5.9.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
6 Central Nervous Systems Therapeutic Drug Monitoring - Recent Developments
6.1 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.2 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.3 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.4 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
6.5 Apr 09, 2019: Avacta Group: Interim results for the period ended 31 January 2019
6.6 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
6.7 Jan 28, 2019: Avacta Group names Dr Sam Williams as Non-Executive Director to the Board
6.8 Jan 21, 2019: Avacta Group announced its AGM business update and a notice of results
6.9 Dec 12, 2018: Avacta Group names Dr. Jose Saro as Chief Medical Officer
6.10 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
6.11 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
6.12 Nov 05, 2018: Siemens Healthineers with a strong finish in the fourth quarter, full year targets for fiscal 2018 achieved
6.13 Oct 23, 2018: Leading Homegrown Medical Group, MWH Medical partners Siemens Healthineers to launch region’s first Asia Reference Centre
7 Appendix
7.1 Methodology
7.2 About the author
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 3: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 4: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table 5: Central Nervous Systems Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 6: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 10: ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
Table 61: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Glossary
List of Figures
Figure 1: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Territory
Figure 3: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Figure 4: Central Nervous Systems Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Diagnostics
  • ARK Diagnostics Inc
  • Avacta Group Plc
  • ELITechGroup Inc
  • Nipro Europe N.V.
  • Pax Neuroscience Inc
  • Saladax Biomedical Inc
  • Siemens Healthineers AG
  • University of Colorado
Note: Product cover images may vary from those shown